| Attributes | Values |
|---|
| rdf:type
| |
| description
| - artículu científicu espublizáu en 2009 (ast)
- vědecký článek publikovaný v roce 2009 (cs)
- 2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած (hyw)
- наукова стаття, опублікована у вересні 2009 (uk)
- 2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված (hy)
- wetenschappelijk artikel (gepubliceerd op 2009/09/01) (nl)
- مقالة علمية (نشرت في سبتمبر 2009) (ar)
- vedecký článok (publikovaný 2009/09/01) (sk)
- scientific journal article (en)
- im September 2009 veröffentlichter wissenschaftlicher Artikel (de)
|
| publication date
| |
| publication date
| |
| language of work or name
| |
| language of work or name
| |
| author name string
| |
| author name string
| - Jaime L. Masferrer
- George Hu
- Ben S. Zweifel
- Gary D. Anderson
- Shanmugam Muthian
- Dana E. Weir
- Fernando A. Happa
- Luz A. Cortes-Burgos
- Matthew J. Graneto
- Medora M. Hardy
- Robert A. Pufahl
- Steven L. Settle
|
| rdfs:label
| - CJ-13610, an orally active inhibitor of 5-lipoxygenase is efficacious in preclinical models of pain (en)
- CJ-13610, an orally active inhibitor of 5-lipoxygenase is efficacious in preclinical models of pain (nl)
- CJ-13610, an orally active inhibitor of 5-lipoxygenase is efficacious in preclinical models of pain (ast)
|
| skos:prefLabel
| - CJ-13610, an orally active inhibitor of 5-lipoxygenase is efficacious in preclinical models of pain (en)
- CJ-13610, an orally active inhibitor of 5-lipoxygenase is efficacious in preclinical models of pain (nl)
- CJ-13610, an orally active inhibitor of 5-lipoxygenase is efficacious in preclinical models of pain (ast)
|
| name
| - CJ-13610, an orally active inhibitor of 5-lipoxygenase is efficacious in preclinical models of pain (en)
- CJ-13610, an orally active inhibitor of 5-lipoxygenase is efficacious in preclinical models of pain (nl)
- CJ-13610, an orally active inhibitor of 5-lipoxygenase is efficacious in preclinical models of pain (ast)
|
| author
| |
| author
| |
| title
| |
| title
| - CJ-13610, an orally active inhibitor of 5-lipoxygenase is efficacious in preclinical models of pain (en)
|
| page(s)
| |
| page(s)
| |
| instance of
| |
| instance of
| |
| PubMed ID
| |
| PubMed ID
| |
| PubMed ID
| |
| published in
| |
| published in
| |
| issue
| |
| volume
| |
| issue
| |
| volume
| |
| DOI
| |
| DOI
| |
| DOI
| - 10.1016/J.EJPHAR.2009.06.058
|
| is about
of | |
| is cites work
of | |
| is cites work
of | |
| is pr:P248
of | |
![[RDF Data]](/fct/images/sw-rdf-blue.png)
![[cxml]](/fct/images/cxml_doc.png)
![[csv]](/fct/images/csv_doc.png)
![[text]](/fct/images/ntriples_doc.png)
![[turtle]](/fct/images/n3turtle_doc.png)
![[ld+json]](/fct/images/jsonld_doc.png)
![[rdf+json]](/fct/images/json_doc.png)
![[rdf+xml]](/fct/images/xml_doc.png)
![[atom+xml]](/fct/images/atom_doc.png)
![[html]](/fct/images/html_doc.png)